QR kód

Mesenchymal Stromal Cells: Potential Option for COVID-19 Treatment

The COVID-19 pandemic has significantly impacted the way of life worldwide and continues to bring high mortality rates to at-risk groups. Patients who develop severe COVID-19 pneumonia, often complicated with ARDS, are left with limited treatment options with no targeted therapy currently available....

Celý popis

Uloženo v:
Hlavní autoři: Dragan Primorac, Martin Čemerin, Vid Matišić, Vilim Molnar, Marko Strbad, Lenart Girandon, Lucija Zenić, Miomir Knežević, Stephen Minger, Denis Polančec
Médium: Artigo
Jazyk:Inglês
Vydáno: MDPI AG 2021-09-01
Edice:Pharmaceutics
Témata:
COVID-19
mesenchymal stromal cells
MSCs
immunomodulation
ARDS
On-line přístup:https://www.mdpi.com/1999-4923/13/9/1481
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Podobné jednotky